Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances 16. Červenec 2018, rubrika EUDA news
9. Červen 2026 New health risks for Europeans in a fast-moving drug market People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This...
